Literature DB >> 10657211

Diphtheria toxoid vaccine effectiveness: A case-control study in Russia.

K M Bisgard1, P Rhodes, I R Hardy, I L Litkina, N N Filatov, A A Monisov, M Wharton.   

Abstract

Prior to the completion of this and other studies, low effectiveness of diphtheria toxoid-containing vaccine was suspected to be a major contributing factor to the diphtheria epidemic that began in the Russian Federation in 1990. A vaccine effectiveness study was done in Moscow by enrolling physician-diagnosed cases and 10 control subjects per case. Controls were matched to cases by age (+/-3 months) and clinic registration. Vaccination history was abstracted from a standardized form for case-patients and from clinic vaccination records for control subjects. Two hundred seventeen case-patients and 2169 matched controls were included in the study. Most controls (92%) had received three or more doses of a diphtheria toxoid vaccine, compared with 72% of case-patients. The vaccine effectiveness for three or more doses was 97% (95% confidence interval: 94.3-98.4). Low vaccine effectiveness was not a contributing factor to the diphtheria epidemic in the Russian Federation. To control and prevent diphtheria epidemics, it is necessary to achieve and maintain high vaccination coverage with three or more doses of diphtheria toxoid among adults and children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657211     DOI: 10.1086/315562

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled Analysis.

Authors:  Shaun A Truelove; Lindsay T Keegan; William J Moss; Lelia H Chaisson; Emilie Macher; Andrew S Azman; Justin Lessler
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

2.  Epidemiology of epidemic diphtheria in three regions, Russia, 1994-1996.

Authors:  C R Vitek; S P Brisgalov; V Y Bragina; A M Zhilyakov; K M Bisgard; M Brennan; O N Kravtsova; B D Lushniak; R Lyerla; S S Markina; P M Strebel
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

3.  Health-Care Workers' Perspectives on Ebola Virus Vaccine: A Focus Group and In-Depth Interview Interventional Study.

Authors:  Dorothy O Esangbedo; Maduka D Ughasoro; Beckie N Tagbo; Adebiyi Olowu; Chukwuemeka Anikene; Chimaobi C Iwegbulam
Journal:  Am J Trop Med Hyg       Date:  2016-07-05       Impact factor: 2.345

Review 4.  Looking beyond COVID-19 vaccine phase 3 trials.

Authors:  Jerome H Kim; Florian Marks; John D Clemens
Journal:  Nat Med       Date:  2021-01-19       Impact factor: 53.440

5.  [Booster doses outside of the Expanded Program on Immunization in two schools in basic education in Yaounde, Cameroon].

Authors:  Clémence Vougmo Meguejio Njua; Félicitée Nguefack; David Chelo; Mathurin Tejiokem; Innocent Kago; Marie Kobela
Journal:  Pan Afr Med J       Date:  2011-10-12

6.  Genomic analysis of endemic clones of toxigenic and non-toxigenic Corynebacterium diphtheriae in Belarus during and after the major epidemic in 1990s.

Authors:  Steffen Grosse-Kock; Valentina Kolodkina; Edward C Schwalbe; Jochen Blom; Andreas Burkovski; Paul A Hoskisson; Sylvain Brisse; Darren Smith; Iain C Sutcliffe; Leonid Titov; Vartul Sangal
Journal:  BMC Genomics       Date:  2017-11-13       Impact factor: 3.969

7.  Risk factors for diphtheria outbreak in children aged 1-10 years in East Kalimantan Province, Indonesia.

Authors:  Iwan Muhamad Ramdan; Rahmi Susanti; Riza Hayati Ifroh; Reny Noviasty
Journal:  F1000Res       Date:  2018-10-10

8.  Persistence of diphtheria, Hyderabad, India, 2003-2006.

Authors:  Sailaja Bitragunta; Manoj V Murhekar; Yvan J Hutin; Padmanabha P Penumur; Mohan D Gupte
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

Review 9.  Whole Genome Sequencing for Surveillance of Diphtheria in Low Incidence Settings.

Authors:  Helena M B Seth-Smith; Adrian Egli
Journal:  Front Public Health       Date:  2019-08-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.